SATELLOS Trademark

Trademark Overview


On Tuesday, October 3, 2023, a trademark application was filed for SATELLOS with the United States Patent and Trademark Office. The USPTO has given the SATELLOS trademark a serial number of 98207571. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, May 31, 2024. This trademark is owned by Satellos Bioscience Inc.. The SATELLOS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing musculoskeletal diseases, disorders, and conditions; Pharmaceutical and biological preparations for promoting the regeneration and repair of damaged muscle tissue; Therapeutic agents for restoring muscle stem cell repair mechanisms and improving muscle functionality

Research and development in the fields of pharmaceuticals, biologics, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Providing medical scientific research information in the fields of pharmaceuticals, biologics, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions
satellos

General Information


Serial Number98207571
Word MarkSATELLOS
Filing DateTuesday, October 3, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, May 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing musculoskeletal diseases, disorders, and conditions; Pharmaceutical and biological preparations for promoting the regeneration and repair of damaged muscle tissue; Therapeutic agents for restoring muscle stem cell repair mechanisms and improving muscle functionality
Goods and ServicesResearch and development in the fields of pharmaceuticals, biologics, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions; Providing medical scientific research information in the fields of pharmaceuticals, biologics, muscle stem cells, muscle repair and regeneration, and musculoskeletal diseases, disorders, and conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSatellos Bioscience Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto M5J2J3
CA

Trademark Events


Event DateEvent Description
Friday, October 6, 2023NEW APPLICATION ENTERED
Thursday, October 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 2, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 2, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 23, 2024ASSIGNED TO EXAMINER
Friday, May 31, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 31, 2024NON-FINAL ACTION WRITTEN
Friday, May 31, 2024NON-FINAL ACTION E-MAILED